Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Tam

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
BMJ Open|December 9, 2025
Ethnic and immigrant disparities in dialysis prevalence and chronic kidney disease trajectories in TorontoTabo Sikaneta, Salome Martin, Istvan Mucsi, et al.
Journal of Clinical Medicine|October 17, 2019
Associations of Calcium from Food Sources Versus Phosphate Binders with Serum Calcium and FGF23 in Hemodialysis PatientsSara Mahdavi, Antonio Bellasi, Karan Nagra, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 14, 2006
Effect of peritoneal dialysis on renal morphology and functionAndrzej Breborowicz, Krzysztof Pawlaczyk, Alicja Polubinska, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 22, 2015
Low-Sodium Versus Standard-Sodium Peritoneal Dialysis Solution in Hypertensive Patients: A Randomized Controlled TrialBolesław Rutkowski, Paul Tam, Frank M van der Sande, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 21, 2004
A cross-sectional immunosurveillance study of anti-EPO antibody levels in CRF patients receiving epoetin alfa in 5 Ontario Renal CentersGeorge Wu, Arturo Wadgymar, Gordon Wong, et al.
International Urology and Nephrology|July 7, 2009
Natural history of CKD stage 4 and 5 patients following referral to renal management clinicAi-Hua Zhang, Paul Tam, Denise LeBlanc, et al.
Clinical Kidney Journal|July 29, 2024
Ethnic and seasonal variations in FGF-23 and markers of chronic kidney disease-mineral and bone disorderHulya Taskapan, Sara Mahdavi, Antonio Bellasi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 3, 2011
A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 StudyRory F McQuillan, Ernest Chiu, Sharon Nessim, et al.
Clinical Toxicology (Philadelphia, Pa.)|August 9, 2011
Aluminum toxicokinetics in peritoneal dialysis patientsCorinne Seng Yue, Megan Christie, Valery Lavergne, et al.
Clinical and Experimental Pharmacology & Physiology|December 1, 2007
Immunochemical characterization of the functional constituents of Tripterygium wilfordii contributing to its anti-inflammatory propertyKwong-Fai Wong, Jacqueline K Chan, Kwong-Leung Chan, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
BMJ Open|December 9, 2025
Ethnic and immigrant disparities in dialysis prevalence and chronic kidney disease trajectories in TorontoTabo Sikaneta, Salome Martin, Istvan Mucsi, et al.
Journal of Clinical Medicine|October 17, 2019
Associations of Calcium from Food Sources Versus Phosphate Binders with Serum Calcium and FGF23 in Hemodialysis PatientsSara Mahdavi, Antonio Bellasi, Karan Nagra, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 14, 2006
Effect of peritoneal dialysis on renal morphology and functionAndrzej Breborowicz, Krzysztof Pawlaczyk, Alicja Polubinska, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 22, 2015
Low-Sodium Versus Standard-Sodium Peritoneal Dialysis Solution in Hypertensive Patients: A Randomized Controlled TrialBolesław Rutkowski, Paul Tam, Frank M van der Sande, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 21, 2004
A cross-sectional immunosurveillance study of anti-EPO antibody levels in CRF patients receiving epoetin alfa in 5 Ontario Renal CentersGeorge Wu, Arturo Wadgymar, Gordon Wong, et al.
International Urology and Nephrology|July 7, 2009
Natural history of CKD stage 4 and 5 patients following referral to renal management clinicAi-Hua Zhang, Paul Tam, Denise LeBlanc, et al.
Clinical Kidney Journal|July 29, 2024
Ethnic and seasonal variations in FGF-23 and markers of chronic kidney disease-mineral and bone disorderHulya Taskapan, Sara Mahdavi, Antonio Bellasi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 3, 2011
A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 StudyRory F McQuillan, Ernest Chiu, Sharon Nessim, et al.
Clinical Toxicology (Philadelphia, Pa.)|August 9, 2011
Aluminum toxicokinetics in peritoneal dialysis patientsCorinne Seng Yue, Megan Christie, Valery Lavergne, et al.
Clinical and Experimental Pharmacology & Physiology|December 1, 2007
Immunochemical characterization of the functional constituents of Tripterygium wilfordii contributing to its anti-inflammatory propertyKwong-Fai Wong, Jacqueline K Chan, Kwong-Leung Chan, et al.
Pageof 7